| tranexamic acid group | SD | control group | SD | p value |
---|---|---|---|---|---|
Number of patients | 46 | Â | 51 | Â | Â |
Sex (M/F) | 31/15 | Â | 27/24 | Â | Â |
Weight (kg) | 81.98 | 14.53 | 79.78 | 13.99 | 0.449 |
Height (cm) | 168.00 | 6.77 | 171.35 | 7.47 | 0.023 |
Age | 67 | 10.5 | 69 | 9.8 | 0.334 |
PTT (s) | 27 | 3.93 | 26 | 4.2 | 0.230 |
Duration of operation (min) | 172.74 | 41.85 | 168.09 | 42.03 | 0.587 |
Surgical procedure | Â | Â | Â | Â | 0.286 |
1 segment PLIF | 9 | Â | 17 | Â | Â |
2 segments PLIF | 23 | Â | 23 | Â | Â |
3 segments PLIF | 12 | Â | 8 | Â | Â |
4 segments PLIF | 1 | Â | 3 | Â | Â |
5 segments PLIF | 1 | Â | 0 | Â | Â |
Surgical procedure | Â | Â | Â | Â | 0.308 |
1 segment instrumentation | 0 | Â | 0 | Â | Â |
2 segments instrumentation | 0 | Â | 0 | Â | Â |
3 segments instrumentation | 0 | Â | 0 | Â | Â |
4 segments instrumentation | 11 | Â | 8 | Â | Â |
5 segments instrumentation | 35 | Â | 43 | Â | Â |
ASA I/II/III | 13/21/12 | Â | 9/16/26 | Â | 0.042 |